![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 45, 44255-44264, November 7, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the Ludwig Institute for Cancer Research and Department of Virology, Faculty of Medicine, Imperial College London, Norfolk Place, London W2 1PG, United Kingdom
The cell cycle-regulated B-Myb transcription factor is required for early embryonic development and is implicated in regulating cell growth and differentiation. In addition to its transcriptional regulatory properties, recent data indicate that B-Myb can release active cyclin/Cdk2 activity from the retinoblastoma-related p107 protein by directly interacting with the p107 N terminus. As this p107 domain has homology to the cyclin-binding domains of the p21Waf1/Cip1 family of cyclin-dependent kinase inhibitors (CKIs), we investigated in this study whether B-Myb could also interact with these CKIs. No in vivo interaction was found with either p21Waf1/Cip1 or p27KIP1, however, binding to p57KIP2 was readily detectable in both in vivo and in vitro assays. The B-Myb-interacting region of p57KIP2 mapped to the cyclin-binding domain. Consistent with this, B-Myb competed with cyclin A2 for binding to p57KIP2, resulting in release of active cyclin/Cdk2 kinase. Moreover, B-Myb partially overcame the ability of p57KIP2 to induce G1 arrest in Saos-2 cells. Despite similarities with previous p107 studies, the B-Myb domains required for interaction with p57KIP2 were quite different from those implicated for p107. Thus, it is evident that B-Myb may promote cell proliferation by a non-transcriptional mechanism that involves release of active cyclin/Cdk2 from p57KIP2 as well as p107.
Received for publication, August 13, 2003
* This work was supported by Cancer Research UK (Project Grant C1317/A2275). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Current address: Friedrich Miescher Institute, Maulbeerstr. 66, Basel CH-4058, Switzerland.
To whom correspondence should be addressed. Tel.: 44-20-7563-7711; Fax: 44-20-7724-8586; E-mail: r.watson{at}imperial.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Yeh, J. P. Miller, T. Gaur, T. D. Capellini, J. Nikolich-Zugich, C. de la Hoz, L. Selleri, T. G. Bromage, A. J. van Wijnen, G. S. Stein, et al. Cooperation between p27 and p107 during Endochondral Ossification Suggests a Genetic Pathway Controlled by p27 and p130 Mol. Cell. Biol., July 15, 2007; 27(14): 5161 - 5171. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Garcia and J. Frampton The transcription factor B-Myb is essential for S-phase progression and genomic stability in diploid and polyploid megakaryocytes J. Cell Sci., April 15, 2006; 119(8): 1483 - 1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Santilli, R. Schwab, R. Watson, C. Ebert, B. J. Aronow, and A. Sala Temperature-dependent Modification and Activation of B-MYB: IMPLICATIONS FOR CELL SURVIVAL J. Biol. Chem., April 22, 2005; 280(16): 15628 - 15634. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |